🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Alexandra Sokolova

Oregon Health & Science University

ORCID: 0000-0003-0821-6503
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile
0.143Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Gender differences in faculty rank and subspecialty choice in academic medical oncology.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11013
Top 70%
0.143DataRank
Top 70%1 citations

Ali Raza Khaki, Alexandra Sokolova, Nancy E. Davidson, Laura Graham

Papers

Driven by 9 papers — median percentile 30. Top paper: “Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference”.

Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference

JAMA Oncology(2020)10.1001/jamaoncol.2020.5161
N/A
0.765DataRank · unranked
163 citations

Eric Q. Konnick, Michael T. Schweizer, Alexandra Sokolova, Petros Grivas, Heather H. Cheng +7 more

Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.11.014
N/A
0.442DataRank · unranked
18 citations

Fadi Taza, Navonil De Sarkar, Alok K. Tewari, Syed Arsalan Ahmed Naqvi, Irbaz Bin Riaz +32 more

Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer

PLoS ONE(2020)10.1371/journal.pone.0239686
N/A
0.360DataRank · unranked
10 citations

Rigo I. Acevedo, Daniel M. Lim, Roman Gulati, Agnes Gawne, Alexandra Sokolova +6 more

Implementation of systematic germline genetic testing (GT) for metastatic prostate cancer (mPC) patients at the Puget Sound VA prostate oncology clinic.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1578
N/A
0.311DataRank · unranked
3 citations

Akemi N. Miyamoto, Darren Pouv, Heather H. Cheng, Bruce Montgomery, Alexandra Sokolova

Genetic Contribution to Metastatic Prostate Cancer

Urologic Clinics of North America(2021)10.1016/j.ucl.2021.03.005
N/A
0.208DataRank · unranked
3 citations

Elias Obeid, Heather H. Cheng, Alexandra Sokolova

Treatment response comparisons between ATM and BRCA2 germline carriers for mCRPC.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.63
N/A
0.165DataRank · unranked
2 citations

Catherine H. Marshall, Rebeca Lozano, Petros Grivas, Celestia S. Higano, Tamara L. Lotan +11 more

Gender differences in faculty rank and subspecialty choice in academic medical oncology.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.11013
Top 70%
0.143DataRank
Top 70%1 citations

Ali Raza Khaki, Alexandra Sokolova, Nancy E. Davidson, Laura Graham

Differential responses to taxanes and PARP inhibitors (PARPi) in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer (mCRPC) patients (pts).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5040
N/A
0DataRank · unranked
0 citations

Emily Nizialek, Jacob E. Berchuck, Panagiotis J. Vlachostergios, Ryan Ashkar, Alexandra Sokolova +14 more

Clinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations

European Urology Focus(2025)10.1016/j.euf.2025.11.011
N/A
0DataRank · unranked
0 citations

Sam Callis, Evan Y. Yu, Scott E. Delacroix, Alexandra Sokolova, Catherine M. Tangen +4 more